
Truveta
Saving lives with data by providing regulatory-grade safety and effectiveness data.

Clinical-grade voice biomarkers for real-time mental health detection.

Kintsugi is a sophisticated AI health-tech platform that utilizes advanced vocal biomarkers to detect signs of clinical depression and anxiety from short clips of free-form speech. Positioned as a leader in the 2026 mental health landscape, Kintsugi's architecture leverages deep learning models trained on the largest datasets of vocal characteristics mapped to clinically validated screening tools like the PHQ-9 and GAD-7. Unlike sentiment analysis tools that rely on NLP and word choice, Kintsugi's engine focuses on acoustic properties—prosody, pitch, and resonance—making it language-agnostic and resilient to cultural variations in expression. The technical infrastructure is designed for seamless integration into telehealth platforms, call centers, and remote patient monitoring systems via a high-performance REST API. By identifying risk earlier than traditional manual screenings, Kintsugi enables healthcare providers to implement proactive interventions, significantly reducing long-term costs and improving patient outcomes. Its 2026 market position is defined by its rigorous clinical validation and its move toward hardware-agnostic, passive monitoring for population health management.
Kintsugi is a sophisticated AI health-tech platform that utilizes advanced vocal biomarkers to detect signs of clinical depression and anxiety from short clips of free-form speech.
Explore all tools that specialize in vocal biomarker extraction. This domain focus ensures Kintsugi delivers optimized results for this specific requirement.
Processes acoustic features rather than semantic content, allowing for detection across 28+ languages.
Algorithms are cross-validated against PHQ-9 and GAD-7 scores in large-scale clinical trials.
Inference latency optimized for under 500ms for short audio clips.
Proprietary preprocessing layers that isolate human vocal folds from environmental interference.
Time-series data tracking for individual users to detect deviations from personal baselines.
Optimized for mobile (iOS/Android) and web-based audio capture across varying microphone quality.
End-to-end encryption with data-at-rest and data-in-transit protocols exceeding healthcare standards.
Application for Enterprise API credentials via the Kintsugi Health portal.
Security and HIPAA compliance audit of the receiving infrastructure.
Integration of the Kintsugi Audio Capture SDK into the client application.
Configuration of audio sampling rates (minimum 8kHz, recommended 16kHz) for optimal feature extraction.
Implementation of OAuth2 authentication for secure API requests.
Sending test audio payloads to the Sandbox environment to validate scoring response.
Mapping Kintsugi risk scores to internal clinical workflows or triage systems.
Establishing data retention policies in accordance with SOC2 requirements.
Pilot phase with a controlled user group to calibrate baseline metrics.
Production deployment with full-scale population monitoring.
All Set
Ready to go
Verified feedback from other users.
"Users and providers praise the tool for its non-invasive nature and high correlation with clinical assessments, though some note the high cost of enterprise implementation."
Post questions, share tips, and help other users.

Saving lives with data by providing regulatory-grade safety and effectiveness data.

Breast AI trusted for better workflow and higher confidence in mammography screening.

Assistive communication solutions for people with disabilities.

Turn your diabetes data points into accessible, actionable, and meaningful insights.

Science-backed supplements for personalized wellness.

Hear everything in a heartbeat with advanced digital stethoscope technology.